HUMIRA® adalimumab

Already using HUMIRA? Sign up to receive tools and resources to help you get the most out of your HUMIRA treatment.

Effects of JIA

JIA’s effect on your child’s body

Look for these common symptoms:

  • Limping
  • Joint swelling, with pain and stiffness which may be more pronounced when awakening
  • Decreased activity level
  • Reluctance to use an arm or leg

Be aware that in addition to joint changes, JIA may interfere with your child’s bone growth and development, and at times, may affect other body systems. Every child is different, and your child may not experience all of the effects of JIA.

Prepare your child

If your child’s physician suspects he or she has JIA, you will likely be referred to a specialist. A pediatric rheumatologist is a doctor who specializes in diagnosing and treating childhood arthritis.

TNF-blockers like HUMIRA can help children with polyarticular JIA

TNF (tumor necrosis factor) is a protein made by the immune system. While the exact cause of JIA is unknown, the disease has been linked to overproduction of TNF. This excess TNF can signal cells to attack normal body tissue and cause inflammation in the tissues of bones, cartilage and joints. HUMIRA (adalimumab), a biologic, can help block the bad effects of TNF in those areas. HUMIRA is used in children 4 years of age and older to reduce the signs and symptoms of moderate to severe polyarticular JIA. HUMIRA can be used alone or with methotrexate or with certain other medicines.

Learn More


Legal Notices/Privacy Policy. Copyright 2008, Abbott Laboratories, Abbott Park, Illinois, U.S.A. If you have any questions about Abbott's HUMIRA.com Web site that have not been answered click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.

64S-108806